Avantor (AVTR) Stock Price, News & Analysis

Company Overview

Avantor (NYSE:AVTR) is a leading global provider of mission-critical products and services that support the life sciences and advanced technologies markets. The company offers a comprehensive portfolio of high-purity chemicals, reagents, consumables, and labware, alongside equipment and instrument solutions designed to enhance research, development, and production workflows. Avantor’s offerings span from basic laboratory supplies to sophisticated biopharma processing materials, catering to customers engaged in drug discovery, clinical research, diagnostics, and precision manufacturing.

Founded through the integration of legacy brands such as J.T. Baker and VWR, Avantor has evolved via strategic acquisitions and organic growth to become a unified platform serving more than 190 countries. Since its initial public offering in 2019, the company has continued to expand both its product lines and geographic footprint, investing in supply chain infrastructure and digital tools to improve accessibility and operational efficiency for customers worldwide.

Avantor’s operations are organized across three core business segments: life sciences solutions, focused on biopharma and clinical diagnostics; applied materials, serving semiconductor, electronics, and specialty chemicals markets; and institutional and government, which supports academic institutions, government research facilities, and industrial laboratories. These segments are underpinned by a global manufacturing and distribution network, ensuring reliable delivery of critical materials and services that enable customers to accelerate innovation and production timelines.

Headquartered in Radnor, Pennsylvania, Avantor is led by Chief Executive Officer Michael Stubblefield and a seasoned executive team with deep expertise in chemical manufacturing, life sciences, and supply chain management. The company emphasizes sustainability, digital transformation, and collaborative partnerships with customers to drive continuous improvement. With a focus on quality, regulatory compliance, and scientific excellence, Avantor aims to support the evolving needs of its diverse customer base and contribute to breakthroughs in health care, energy, and advanced materials.

Key Stats

• Today's Range: $13.45 to $13.76
• 50-Day Range: $11.95 to $13.91
• 52-Week Range: $11.82 to $28.00
• Volume: 9.93 million shs
• Average Volume: 8.54 million shs
• Market Capitalization: $9.27 billion
• P/E Ratio: 13.08
• Dividend Yield: N/A
• Price Target: $18.14
• Consensus Rating: Hold

Avantor Stock Analysis - MarketRank™

Avantor scored higher than 99% of companies evaluated by MarketBeat, and ranked 26th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Avantor has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 5 buy ratings, 7 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Avantor has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 13.21%

Earnings Growth

Earnings for Avantor are expected to grow by 13.21% in the coming year, from $1.06 to $1.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Avantor is 13.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avantor is 13.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.23.

Price to Earnings Growth Ratio

Avantor has a PEG Ratio of 1.44. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Avantor has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.96% of the float of Avantor has been sold short.

Short Interest Ratio / Days to Cover

Avantor has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Avantor has recently increased by 5.34%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avantor does not currently pay a dividend.

Dividend Growth

Avantor does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.2 / 5
• Environmental Score: -2.36

Percentage of Shares Shorted

4.96% of the float of Avantor has been sold short.

Short Interest Ratio / Days to Cover

Avantor has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Avantor has recently increased by 5.34%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.48

News Sentiment

Avantor has a news sentiment score of 1.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Avantor this week, compared to 12 articles on an average week.

Search Interest

3 people have searched for AVTR on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Avantor insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,027,630.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.20% of the stock of Avantor is held by insiders.

Percentage Held by Institutions

95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AVTR Stock Analysis - Frequently Asked Questions

How have AVTR shares performed this year?

Avantor's stock was trading at $21.07 at the beginning of 2025. Since then, AVTR shares have decreased by 35.5% and is now trading at $13.60.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) posted its quarterly earnings data on Friday, April, 25th. The company reported $0.23 EPS for the quarter, hitting analysts' consensus estimates of $0.23. The firm's revenue was down 5.9% compared to the same quarter last year.
Read the conference call transcript.

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Top institutional investors of Avantor include Perpetual Ltd (0.26%), Pacific Capital Partners Ltd (0.10%), Reinhart Partners LLC. (0.08%) and Balefire LLC (0.04%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, Gregory L Summe, Christophe Couturier, James Bramwell, Steven W Eck, Thomas A Szlosek and Joseph R Massaro.
View institutional ownership trends.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Humana (HUM), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 4/25/2025
• Today: 7/13/2025
• Next Earnings (Estimated): 8/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NYSE:AVTR
• CIK: 1722482
• Web: www.avantorsciences.com
• Phone: (610) 386-1700
• Fax: N/A
• Employees: 13,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Avantor: $18.14
• High Price Target: $25.00
• Low Price Target: $14.00
• Potential Upside/Downside: +33.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.42
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.04
• Trailing P/E Ratio: 13.08
• Forward P/E Ratio: 12.83
• P/E Growth: 1.44
• Net Income: $711.50 million
• Net Margins: 10.70%
• Pretax Margin: 12.85%
• Return on Equity: 11.93%
• Return on Assets: 5.50%

Debt

• Debt-to-Equity Ratio: 0.54
• Current Ratio: 1.12
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $6.69 billion
• Price / Sales: 1.39
• Cash Flow: $1.61 per share
• Price / Cash Flow: 8.45
• Book Value: $8.75 per share
• Price / Book: 1.55

Miscellaneous

• Outstanding Shares: 681,430,000
• Free Float: 673,253,000
• Market Cap: $9.27 billion
• Optionable: Optionable
• Beta: 1.05